Ezetimibe--a new cholesterol-lowering drug.

  • Published 2004 in Drug and therapeutics bulletin


Use of statin therapy is a key first-line approach in preventing coronary heart disease events and stroke in people at increased risk of developing such complications. Ezetimibe (Ezetrol - MSD-Schering-Plough), the first licensed azetidinone drug, is being promoted as an adjunct to statin therapy to achieve greater reductions in blood cholesterol… (More)


  • Presentations referencing similar topics